[Factors related to adjuvant ovarian function suppression in premenopausal breast cancer patients].

医学 依西美坦 三苯氧胺 乳腺癌 内科学 妇科 肿瘤科 佐剂 癌症
作者
Yue Liang,Xiaosong Chen,Jiayi Wu,Ou Huang,Yu Zong,Lijing Nie,Qiong Fang,Jian-Rong He,Li Zhu,Weiguo Chen,Yafen Li,Kunwei Shen
出处
期刊:Chinese journal of oncology [BioMed Central]
卷期号:38 (5): 357-62
标识
DOI:10.3760/cma.j.issn.0253-3766.2016.05.007
摘要

To analyze the applied condition of ovary function suppression (OFS) before and after joint analysis of TEXT and SOFT trials and SOFT trial, and to identify the relevant factors of OFS usage.The analysis was performed in premenopausal women with hormone receptor (HR) positive breast cancer receiving surgical treatment from Apr 2013 to Oct 2015 in Ruijin Hospital, Shanghai Jiaotong University School of Medicine. Adjuvant treatment strategy was made in the multidisciplinary team (MDT) meetings. We analyzed the applied condition of OFS before and after joint analysis, SOFT trial and its relevant factors.Among 454 patients, 114 (25.1%) patients received OFS. Before the results of joint analysis came out, all the patients (38/38) received OFS together with tamoxifen (TAM); after the results came out, clinicians began to put OFS with exemestane into practice, among 76 patients, 41(53.9%) patients received OFS with exemestane while 35 (46.1%) patients received OFS together with TAM. Before the results of SOFT trial came out, 71 out of 310 (22.9%) patients received OFS while 43 out of 144 (29.9%) patients received OFS after that. No significant difference was found between the proportion of patients receiving OFS before and after the results of SOFT trial came out (P=0.112). Age, histological grade, pN status, Ki-67 status, molecular subtype and acceptance of chemotherapy were correlated with OFS treatment (P<0.05). Age, tumor grade and pN were independent significant predictors of OFS usage.After the results of joint analysis came out, clinicians began to apply OFS with exemestane to premenopausal women with HR positive breast cancer. There is no significant difference between the proportion of patients receiving OFS before and after SOFT trial. Age, tumor grade and pN status are independent significant predictors of OFS treatment. Patients younger than 40, with histological grade Ⅱ or Ⅲ tumor and with pN1 or pN2 status are prone to receive OFS.

科研通智能强力驱动
Strongly Powered by AbleSci AI
更新
PDF的下载单位、IP信息已删除 (2025-6-4)

科研通是完全免费的文献互助平台,具备全网最快的应助速度,最高的求助完成率。 对每一个文献求助,科研通都将尽心尽力,给求助人一个满意的交代。
实时播报
刚刚
yu发布了新的文献求助10
1秒前
1秒前
所所应助chemcarbon采纳,获得10
1秒前
科研通AI2S应助WN采纳,获得10
2秒前
Ally发布了新的文献求助30
2秒前
李j1发布了新的文献求助10
3秒前
3秒前
NexusExplorer应助AMD采纳,获得10
4秒前
sys549发布了新的文献求助10
5秒前
8秒前
9秒前
10秒前
Arlen完成签到,获得积分10
11秒前
加油女王完成签到 ,获得积分10
12秒前
123发布了新的文献求助10
12秒前
缪甲烷完成签到,获得积分10
12秒前
wk完成签到,获得积分10
13秒前
13秒前
唯爱林发布了新的文献求助10
14秒前
15秒前
15秒前
平常听枫完成签到,获得积分10
15秒前
16秒前
72727完成签到,获得积分10
17秒前
pagoda完成签到,获得积分10
18秒前
18秒前
庞扬完成签到,获得积分10
19秒前
合适苗条发布了新的文献求助10
20秒前
WWZ发布了新的文献求助10
21秒前
22秒前
宁霸完成签到,获得积分0
22秒前
22秒前
庞扬发布了新的文献求助10
23秒前
小蘑菇应助啸西风采纳,获得10
23秒前
田様应助啊棕采纳,获得10
24秒前
今后应助合适苗条采纳,获得10
25秒前
超级的鞅发布了新的文献求助10
25秒前
小蘑菇应助Ally采纳,获得10
25秒前
Bb发布了新的文献求助10
25秒前
高分求助中
(应助此贴封号)【重要!!请各用户(尤其是新用户)详细阅读】【科研通的精品贴汇总】 10000
Petrucci's General Chemistry: Principles and Modern Applications, 12th edition 600
FUNDAMENTAL STUDY OF ADAPTIVE CONTROL SYSTEMS 500
微纳米加工技术及其应用 500
Nanoelectronics and Information Technology: Advanced Electronic Materials and Novel Devices 500
Performance optimization of advanced vapor compression systems working with low-GWP refrigerants using numerical and experimental methods 500
Constitutional and Administrative Law 500
热门求助领域 (近24小时)
化学 材料科学 医学 生物 工程类 有机化学 生物化学 物理 纳米技术 计算机科学 内科学 化学工程 复合材料 物理化学 基因 遗传学 催化作用 冶金 量子力学 光电子学
热门帖子
关注 科研通微信公众号,转发送积分 5300488
求助须知:如何正确求助?哪些是违规求助? 4448338
关于积分的说明 13845737
捐赠科研通 4334050
什么是DOI,文献DOI怎么找? 2379324
邀请新用户注册赠送积分活动 1374471
关于科研通互助平台的介绍 1340113